{"id":16912,"date":"2022-04-25T12:11:41","date_gmt":"2022-04-25T16:11:41","guid":{"rendered":"https:\/\/www.emilysentourage.org\/?p=16912"},"modified":"2022-05-03T13:46:02","modified_gmt":"2022-05-03T17:46:02","slug":"178882-awarded-in-funding-for-cystic-fibrosis-research","status":"publish","type":"post","link":"https:\/\/www.emilysentourage.org\/sv\/178882-awarded-in-funding-for-cystic-fibrosis-research\/","title":{"rendered":"EE tillk\u00e4nnager $178,882 i finansiering f\u00f6r forskning om cystisk fibros"},"content":{"rendered":"

I februari 2022 meddelade vi att Emily's Entourage (EE) tilldelats <\/span>$440.000 i finansiering<\/span><\/a> f\u00f6r tv\u00e5 nya anslag f\u00f6r att fr\u00e4mja forskning och l\u00e4kemedelsutveckling inom cystisk fibros (CF). Idag \u00e4r vi glada \u00f6ver att kunna ber\u00e4tta att EE har beviljat ytterligare $178,882 till en tredje bidragsmottagare, Mitochon Pharmaceuticals, Inc. f\u00f6r att fr\u00e4mja forskning om mitokondriell dysfunktion hos personer med CF.<\/span><\/p>\n

Ytterligare information om detta bidrag finns nedan.<\/span><\/p>\n

MOTTAGARE AV BIDRAG:<\/strong><\/h2>\n
\n

Terapeutisk nytta med MP-101 f\u00f6r cystisk fibros
\n<\/b><\/h3>\n

\"\"<\/p>\n

\"\"<\/p>\n

John G. Geisler, PhD, CSO och medgrundare (v\u00e4nster)<\/span>
\nRobert Alonso, MBA, VD och medgrundare (h\u00f6ger)<\/span><\/p>\n

Mitochon Pharmaceuticals, Inc.<\/span><\/i><\/p>\n

Mitokondriell dysfunktion \u00e4r ett ofta f\u00f6rbisett problem hos personer med CF. Den k\u00e4nnetecknas av f\u00f6rs\u00e4mrad energiproduktion och generering av enorma m\u00e4ngder fria radikaler som \u00e4r giftiga f\u00f6r alla celler i kroppen. Mitochons arbete representerar en ny strategi f\u00f6r CF genom anv\u00e4ndningen av en mitokondriell modulator, MP-101, f\u00f6r att minska produktionen av fria radikaler och mitokondriell kalcium\u00f6verbelastning, och d\u00e4rigenom minska inflammatoriska reaktioner och p\u00e5f\u00f6ljande v\u00e4vnadsskador. MP-101 kommer att testas i en modell av CF i iller och kan, om det visar sig framg\u00e5ngsrikt, komma att testas p\u00e5 patienter med CF. <\/span><\/p>\n

\n

L\u00e4s mer om de \u00f6vriga tv\u00e5 mottagarna av bidrag fr\u00e5n de sex omg\u00e5ngarna, <\/span>tillk\u00e4nnagavs i februari 2022<\/span><\/a>, vars arbete fokuserar p\u00e5 utvecklingen av en ny modell f\u00f6r nonsensmutationer i iller och en ny form av genterapi med hj\u00e4lp av lipidnanopartiklar.\u00a0<\/span><\/p>\n

Vi \u00e4r tacksamma f\u00f6r alla de h\u00e4ngivna forskare som leder arbetet med att snabbt fylla kritiska behov f\u00f6r alla m\u00e4nniskor med CF - ingen l\u00e4mnas efter! Visa en <\/span>omfattande f\u00f6rteckning<\/span><\/a> av alla beviljade forskningsanslag.<\/span><\/p>","protected":false},"excerpt":{"rendered":"

I februari 2022 meddelade vi att Emily's Entourage (EE) beviljade $440 000 i finansiering f\u00f6r tv\u00e5 nya anslag f\u00f6r att fr\u00e4mja forskning och l\u00e4kemedelsutveckling inom cystisk fibros (CF). Idag \u00e4r vi glada \u00f6ver att kunna ber\u00e4tta att EE har beviljat ytterligare $178 882 till en tredje bidragsmottagare, Mitochon Pharmaceuticals, Inc. f\u00f6r att fr\u00e4mja forskning om mitokondriell dysfunktion hos personer med cystisk fibros.... <\/p>\n

<\/div>\n

L\u00e4s mer om<\/a><\/p>","protected":false},"author":1281,"featured_media":16960,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"EE Announces $178,882 in Funding for Cystic Fibrosis Research","_seopress_titles_desc":"We are thrilled to share that EE has awarded an additional $178,882 to a third grant recipient, Mitochon Pharmaceuticals, Inc., to advance research into mitochondrial dysfunction in those with CF.","_seopress_robots_index":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16912","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"jetpack_featured_media_url":"https:\/\/www.emilysentourage.org\/wp-content\/uploads\/mitochon.png","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/16912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/users\/1281"}],"replies":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/comments?post=16912"}],"version-history":[{"count":5,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/16912\/revisions"}],"predecessor-version":[{"id":16920,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/posts\/16912\/revisions\/16920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/media\/16960"}],"wp:attachment":[{"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/media?parent=16912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/categories?post=16912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.emilysentourage.org\/sv\/wp-json\/wp\/v2\/tags?post=16912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}